Skip to main content
SpringerLink
Log in

Effects of melatonin in reducing the toxic effects of doxorubicin

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Anthracycline antibiotics, such as doxorubicin and daunorubicin, constitute a group of wide spectrum therapeutic agents. Application of these drugs in chemotherapy is limited because of their toxic effects. Melatonin, the main secretory product of pineal gland, was recently found as a free radical scavenger and antioxidant.

We decided to evaluate the tissue protective effect of melatonin against toxic effects of doxorubicin in six groups of rats. Rats were given doxorubicin (Dx) (45 mg/kg dose), melatonin (MEL) (10 mg/kg), first doxorubicin and then melatonin (DM), first melatonin and then doxorubicin (MD).

The degree of kidney, lung, liver and brain cells' alterations were examined biochemically.

In doxorubicin-treated group, malondialdehyde (MDA) levels of kidney, lung, liver and brain tissues were significantly increased but glutathione (GSH) levels were decreased compared to control rats. In the group in which first doxorubicin and then melatonin were given, MDA levels were significantly decreased compared to the doxorubicin-treated group.

In doxorubicin-treated group, serum levels of creatinine, uric acid, blood urea nitrogen (BUN), Gamma-glutamyl transpeptidase (GGT) and Lactic acid dehydrogenase (LDH) were significantly increased while serum albumin and total protein levels were significantly decreased compared to control rats.

Melatonin decreased the intensity of the changes produced by the administration of doxorubicin alone. Melatonin was quite efficient in reducing the formation of lipid peroxidation, restoring the tissue GSH contents and alterations of serum levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Agapito MT, Antolin Y, del Brio MT, Lopes-Burillo S, Pablos MI, Recio JM: Protective effect of melatonin against adriamycin toxicity in the rat. J Pineal Res 31: 23–30, 2001

    Article  PubMed  CAS  Google Scholar 

  2. Olson RD, Mushlin PS: Doxorubicin cardiotoxicity: analysis of prevailing hypotheses.The FASEB Journal 4: 3076–3086, 1990

    PubMed  CAS  Google Scholar 

  3. Rajagopalan S, Politi PM, Sinha BK, Myers E: Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res 48(17): 4766–4769, 1988

    PubMed  CAS  Google Scholar 

  4. Singal PK, Siveski-Iliskovic N, Hill M, Thomas TP, Li T: Combination therapy with probucol prevents adriamycin-induced cardiomyopathy. J Mol Cell Cardiol 27: 1055–1063, 1995

    Article  PubMed  CAS  Google Scholar 

  5. Reiter R, Tang L, Garcia JJ, Munoz-Hoyos A: Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 60: 2255–2271, 1997

    Article  PubMed  CAS  Google Scholar 

  6. Neri B, de Leonardis V, Gemelli MT, di Loro F, Mottola A, Ponchietti R, Raugei A, Cini G: Melatonin as biological response modifier in cancer patients. Anticancer Res 18: 1329–1332, 1998

    PubMed  CAS  Google Scholar 

  7. Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC: Melatonin, hydroxy radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 14: 151–168, 1993

    Article  PubMed  CAS  Google Scholar 

  8. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55: PL 271–276, 1994

    Article  CAS  Google Scholar 

  9. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C: Melatonin is a scavenger of peroxynitrite. Life Sci 60: PL 169–174, 1997

    Article  CAS  Google Scholar 

  10. Li ZR, Reiter RJ, Fujimori O, Oh CS, Duan YP: Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin. J Pineal Res 22: 117–123, 1997

    Article  PubMed  CAS  Google Scholar 

  11. Bertuglia S, Marchiafava PL, Colantuoni A: Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31: 947–952, 1996

    Article  PubMed  CAS  Google Scholar 

  12. Duncker DJ, Verdouw PD: Has melatonin a future as a cardioprotective agent? Cardiovasc. Drugs and Therapy 15: 205–207, 2001

    Article  CAS  Google Scholar 

  13. Montilla PL, Tunez IF, Munoz de Agueda C, Gascon FL, Soria JV: Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats. J Pineal Res 25(2): 86–93, 1998

    Article  PubMed  CAS  Google Scholar 

  14. Montilla P, Tunez I, Munoz MC, Lopez A, Soria JV: Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Nephron 76(3): 345–350, 1997

    Article  PubMed  CAS  Google Scholar 

  15. Rapozzi V, Comelli M, Mavelli I, Sentjurc M, Schara M, Perissin L, Giraldi T: Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, adriamycin. In vivo 13(1): 45–50, 1999

    PubMed  CAS  Google Scholar 

  16. Baydas G, Ercel E, Canatan H, Dönder E, Akyol A: Effect of melatonin on oxidative status of rat brain, liver and kidney tissues under constant light exposure. Cell Biochem Funct 19: 37–41, 2001

    Article  PubMed  CAS  Google Scholar 

  17. Timlioğlu Ö, Kutsal Ş, Özkur M, Uluoğlu Ö, Arıcıoğlu A, Çevik C, Düzgün E, Sancak B, Poyraz A: The effect of EGb 761 on the doxorubicin cardiomyopathy. Research Communications in Molecular Pathology and Pharmacology 106: 181–192, 1999

    Google Scholar 

  18. Akbulut KG, Gönül B, Akbulut H: Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats.Gerontology 45: 67–71, 1999

    Article  PubMed  CAS  Google Scholar 

  19. Kurtel H, Granger DN, Tso P, Grisham MB: Vulnerability of intestinal interstitial fluid to oxidant stres. Am J Physiol 263: G573–578, 1992

    PubMed  CAS  Google Scholar 

  20. Casini A, Ferrali M, Pompella A, Maellaro E, Comborti M: Lipid reroxidation and cellular damage in extrahepatic tissues of bromobenzene intoxicated mice. Am J Pathol 123: 520–531, 1986

    PubMed  CAS  Google Scholar 

  21. Oz E, Erbas D, Sürücü HS, Düzgün E: Prevention of doxorubicin induced cardiotoxicity by melatonin. Molecular and Cellular Biochemistry, in press

  22. Booser DJ, Hortobagyi GN: Anthracycline antibiotics in cancer therapy. Drugs 47: 223–258, 1994

    Article  PubMed  CAS  Google Scholar 

  23. Grenier MA, Lipshultz SE: Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25: 72–85, 1998

    PubMed  CAS  Google Scholar 

  24. Hortobagyi GN: Anthracyclines in the treatment of cancer. Drugs 54: 1–7, 1997

    Article  PubMed  CAS  Google Scholar 

  25. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55: PL 271–276, 1994

    Article  CAS  Google Scholar 

  26. Hardeland R, Reiter RJ, Poeggeler B, Tan DX: The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 17: 347–357, 1993

    Article  PubMed  CAS  Google Scholar 

  27. Meister A: Glutathione deficiency produced by inhibition of it's synthesis and it's reversal: Applications in research and therapy. Pharmacol Ther 51: 155–194, 1991

    Article  PubMed  CAS  Google Scholar 

  28. Tunez I, del Carmen Munoz M, Feijoo M, Valdervira ME, Rafael Munoz-Castaneda J, Montilla P: Melatonin effect on renal oxidative stress under constant light exposure. Cell Biochem Funct 21(1): 35–40, 2003

    Article  PubMed  CAS  Google Scholar 

  29. Tunez L, Munoz MC, Feijoo-Lopez AL, Valdvira E, Bujalance-Arenas L, Montilla P: Effect of melatonin on hyperlipidemic nephropathy under constant light exposure. J Physiol Biochem 58(2): 109–114, 2002

    Article  PubMed  CAS  Google Scholar 

  30. Montilla P, Tunez I, Munoz MC, Soria JV, Lopez A: Antioxidative effect of melatonin in rat brain oxidative stress induced by adriamycin. Rev Esp Fisiol 53(3): 301–305, 1997

    PubMed  CAS  Google Scholar 

  31. Rapozzi V, Zorzet S, Comelli M, Mavelli I, Perissin L, Giraldi T: Melatonin} decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma. Life Sciences 63(19): 1701–1713, 1998

    Article  PubMed  CAS  Google Scholar 

  32. Granzotti M, Rapozzi V, Decorti G, Giraldi T: Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells. J Pineal Res 31: 206–213, 2001

    Article  Google Scholar 

  33. Dziegiel P, Suder E, Surowiak P, Jethon Z, Rabczynski J, Januszewska L, Sopel M, Zabel M: Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. J Pineal Res 33: 95–100, 2002

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, Faculty of Medicine, Gazi University, Ankara, Turkey

    Eser Öz

  2. Department of Public Health, Faculty of Medicine, Gazi University, Ankara, Turkey

    Mustafa N. İlhan

  3. Uğurlu sokak, 38/4 Kurtuluş, Ankara, 06600, Turkey

    Eser Öz

Authors
  1. Eser Öz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mustafa N. İlhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eser Öz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Öz, E., İlhan, M.N. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol Cell Biochem 286, 11–15 (2006). https://doi.org/10.1007/s11010-005-9003-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-005-9003-8

Keywords

Search

Navigation